• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT GMBH ARCHITECT INSULIN REAGENT KIT; RADIOIMMUNOASSAY, IMMUNOREACTIVE INSULIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT GMBH ARCHITECT INSULIN REAGENT KIT; RADIOIMMUNOASSAY, IMMUNOREACTIVE INSULIN Back to Search Results
Catalog Number 08K41-74
Device Problem High Test Results (2457)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/06/2021
Event Type  malfunction  
Manufacturer Narrative
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.Patient information: no specific patient information was provided.Patient identifier: complete entry = (b)(6).Reporter complete entry = (b)(6).
 
Event Description
The customer obtained a falsely elevated architect insulin result.On (b)(6) 2021, sample id (b)(6) generated 361.4 pmol/l.The sample was retested twice on (b)(6) 2021 and generated 253.62 and 250.22 pmol/l.No impact to patient management was reported.
 
Manufacturer Narrative
Investigation of the customer's issue included a review of the complaint text, complaint activity, trending reports, labeling and device history records.Additionally, in-house retained kit testing of the complaint lot was performed.Return testing was not completed as returns were not available.Review of the trending reports for the architect insulin assay did not identify any trends.Device history record review for the complaint lot did not identify any potential non-conformances, deviations or non-conformances.Labeling was reviewed and sufficiently addresses the complaint issue.Accuracy testing was performed to evaluate the performance of reagent lot 29821lp68.An internal insulin panel was tested with retained kits of the complaint lot.Acceptance criteria was met indicating the product performance is acceptable.Based on this investigation, no systemic issue or deficiency of the architect insulin assay was identified.H4 device mfg date was changed from 4/7/2021 to 4/27/2021.The incorrect date was entered in error.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT INSULIN REAGENT KIT
Type of Device
RADIOIMMUNOASSAY, IMMUNOREACTIVE INSULIN
Manufacturer (Section D)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM  65205
Manufacturer (Section G)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM   65205
Manufacturer Contact
christian lee
100 abbott park road
dept. 09b9, lc cp01-3
abbott park, IL 60064-3537
2246682940
MDR Report Key12668451
MDR Text Key278015903
Report Number3002809144-2021-00610
Device Sequence Number1
Product Code CFP
Combination Product (y/n)N
Reporter Country CodeCH
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 11/17/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/20/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/23/2022
Device Catalogue Number08K41-74
Device Lot Number29821LP68
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/05/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/27/2021
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARC I2000SR INST, 03M74-02, ISR60522
-
-